Motivational interviewing can help a person explore uncertainty about changing substance use and develop reasons for action that matter to them. In rehab, it should be a purposeful clinical conversation connected with the wider treatment plan. Ask how the program uses the approach, who provides it, and what care follows when the person identifies a goal.
MI is not a guarantee that someone will agree with every recommendation or commit to a particular residential package. A useful program explains how it respects the person’s perspective while providing clear clinical information and access to appropriate treatment.
Understand ambivalence before judging motivation
SAMHSA’s Treatment Improvement Protocol 35 describes motivational interviewing as an approach to ambivalence about change. Someone may want the consequences of substance use to improve while also having reasons to continue. Exploring that tension is part of the work.
A person might be worried about health, relationships, or work and still be unsure what change would require. They may have had an unhelpful treatment experience or doubt that another attempt is feasible. These concerns provide information for a clinical conversation rather than a fixed label of being unmotivated.
Ask how the program responds when a prospective patient has mixed feelings. Does a clinician explore the concerns and explain options? Is the person allowed to ask questions about the proposed plan? A statement of enthusiasm during admissions is not a complete measure of readiness for treatment.
Look for a collaborative approach
SAMHSA emphasizes partnership, acceptance, compassion, and drawing on the person’s own values and resources. The clinician brings expertise, while the patient brings knowledge of their life and priorities. MI uses that relationship to support a considered change process.
Ask how the clinician learns what the person wants from treatment. The conversation should allow the patient to describe both hopes and concerns. It should not be limited to obtaining agreement with goals that were decided before assessment.
Collaboration does not mean withholding relevant health information. A clinician can explain risks, treatment options, and the reasons for a recommendation while checking understanding and inviting a response. The issue is how information becomes part of an informed decision.
For an international program, distinguish a clinical conversation from a booking discussion. An admissions representative may answer practical questions, but the treatment rationale and the person’s clinical needs should be addressed by an appropriate professional.
Understand the four overlapping processes
SAMHSA describes engaging, focusing, evoking, and planning as overlapping processes in MI. They help explain the work without implying that every person moves through a fixed sequence on a predetermined schedule. A conversation may return to an earlier question when new information emerges.
Engaging concerns the working relationship. Focusing clarifies what change is being discussed. Evoking explores the person’s own reasons and confidence. Planning turns an agreed direction into practical next steps when the person is ready to do that work.
| MI process | Question for evaluating a program |
|---|---|
| Engaging | How does the clinician understand the person’s perspective and establish a useful working relationship? |
| Focusing | How are the treatment agenda and change goals agreed? |
| Evoking | How does the conversation explore the person’s own reasons, strengths, and uncertainty? |
| Planning | How are possible next steps made realistic and connected with available care? |
Ask for a plain-language explanation of how MI fits the proposed stay. It may be used in assessment, individual sessions, or conversations about a particular treatment decision. The program should identify the role rather than simply adding the acronym to its list of therapies.
Examine the conversation, not just the label
SAMHSA describes core skills including open questions, recognizing strengths, reflective listening, and summarizing. These skills help the clinician understand what the person means and explore change. Their presence is more informative than a claim that staff are good at persuading people.
Ask how staff are trained and supported in the approach. A single introductory course or a general communication style does not explain the depth of clinical practice. The program should be able to describe relevant training, supervision, or feedback without promising perfect delivery.
The patient should be able to correct a misunderstanding. If a clinician summarizes the person’s goals inaccurately, there needs to be room to clarify them. A productive conversation does not require the person to accept an interpretation simply because it appears in a treatment document.
Consider a hypothetical patient who wants help with alcohol-related problems but is uncertain about residential care abroad. MI could help explore the person’s reasons and concerns. It should not be used to make agreement to one provider’s package the definition of successful motivation.
Connect MI with substance-specific treatment
NIAAA describes motivational enhancement approaches among evidence-based behavioral options for alcohol problems. Treatment may also involve other behavioral methods, appropriate medication, and recovery support. A motivational conversation is one part of the possible care plan.
Ask what will happen after a goal is identified. Which intervention addresses the substance use disorder? Who provides it? How does the program help the person use it? Motivation without a workable treatment pathway leaves an important task unfinished.
For example, the person may decide to attend ongoing clinical care, review medication options, or practice a particular coping strategy. The program should help translate that decision into an arrangement that can actually be used rather than recording the intention alone.
Our CBT comparison illustrates how a different behavioral treatment can contribute practical work. Ask how the methods complement one another and how the patient will understand their different purposes.
Keep medical care accessible
The CDC states that declining psychosocial treatment should not prevent or delay medication for opioid use disorder. This illustrates why access to clinically appropriate care should not depend on a person demonstrating the exact attitude a program expects.
If withdrawal or another urgent medical issue is possible, it needs appropriate assessment. A conversation about readiness does not replace that assessment. The program should explain how medical and psychiatric needs are addressed while the person is considering longer-term change.
Ask how staff distinguish uncertainty about a treatment choice from an immediate clinical need. The person may need information, time, or a different option while still requiring care. The treatment plan should reflect those distinctions.
If a proposal is unclear, ask the treating clinician to explain the options and their likely benefits and limits.
Address co-occurring conditions
NIMH recommends coordinated assessment and treatment for co-occurring mental health and substance use disorders. A difficulty participating in care may need assessment in that broader context. It should not automatically be explained as insufficient motivation.
Ask how the clinician considers mood symptoms, attention difficulties, trauma-related concerns, physical health, and the person’s understanding of the plan. The relevant professionals should communicate so that the patient receives consistent explanations and practical support.
Our integrated care guide helps evaluate that coordination. MI may support discussions about treatment, but the program still needs the clinical capability to address the conditions identified.
Include practical barriers in the plan
A person can want change and still face barriers to using care. Ask how the program addresses appointment access, cost, transport, communication, caregiving responsibilities, and the availability of support. These are practical questions that cannot be solved solely through encouragement.
For treatment abroad, discuss what happens when the person returns to the circumstances that shaped the original difficulty. The plan should identify which supports can remain and which need replacing. A decision made inside a protected setting must become usable outside it.
Ask whether the person can review options that fit their circumstances, including local care. If the only acceptable outcome of the discussion is purchasing a longer stay, the purpose of the conversation needs clarification.
Use family involvement thoughtfully
When the patient wants family participation, clarify what role it will serve. Relatives may have concerns and useful information, but their goals may not be identical to the patient’s. The clinician should make space to understand the perspectives without turning the session into a contest.
Ask how consent and privacy are handled, especially when a relative pays for treatment. Financial support and clinical decision-making are separate matters. The person receiving care should understand who may receive information and how their preferences are recorded.
Evaluate progress through action and review
Ask how the team reviews agreed goals and next steps. A statement of commitment can be meaningful, but it is not the same as having access to ongoing treatment or being able to use a plan. The review should examine both intention and practical follow-through.
If a goal changes or an action is not completed, the clinician can revisit the reasons, barriers, and available options. The program should explain how it responds constructively instead of treating a setback as proof that the person never wanted help.
Our relapse prevention comparison shows how agreed intentions can connect with specific support and clinical review. The question is what the person and team will do when circumstances become difficult.
Before discharge, confirm the next appointments and the people responsible for continuing care. The aftercare guide helps make those arrangements concrete. MI is most useful in a program comparison when its role is clear and it leads into care the patient can understand and use.